PHILADELPHIA (AP) — Federal prosecutors say a pharmaceutical firm improperly used a charity to pay kickbacks that subsidized Medicare patients’ copayment obligations, allowing the firm to keep raising prices for the drug. The suit filed Wednesday claims the scheme was designed to enable Mallinckrodt to raise the price of Acthar from $50 to $32,000. The... Read More
